Advanced Biomed reported revenue of -$0.00M and net income of -$0.49M for the quarter ended Mar 2026. This income statement covers 10 quarters of results from Dec 2023 through Mar 2026, standardized by Business Quant from the company’s SEC filings.
| Income StatementIncome Statement | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||
| Revenue | -112.00 | |||||||||
| Operating items | ||||||||||
| Research & DevelopmentR&D | 0.19M | 0.31M | 0.21M | 0.18M | 0.21M | 0.22M | 0.31M | 0.24M | 0.19M | 0.24M |
| Selling, General & AdministrativeSG&A | 0.46M | 0.43M | 0.50M | 0.34M | 0.07M | 0.35M | 1.64M | 0.29M | 0.21M | 0.28M |
| Operating ExpensesOpex | 0.65M | 0.75M | 0.70M | 0.52M | 0.28M | 0.57M | 1.95M | 0.52M | 0.40M | 0.52M |
| EBIT | -0.15M | -1.06M | -0.81M | -0.27M | -0.58M | -1.20M | -1.50M | -0.39M | 7.00M | -0.49M |
| Non-operating items | ||||||||||
| Non Operating Investment IncomeNon-Op. Investment Inc. | 7.35M | |||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.02M | 104.00 | 0.03M | 10.00 | 0.02M | 26.00 | 0.01M | 448.00 | 0.01M | |
| Other Non Operating IncomeOther Non Op Inc. | 0.49M | -0.31M | 0.45M | 0.25M | -0.31M | -0.63M | 0.97M | 0.14M | 0.04M | 0.03M |
| Non Operating IncomeNon Op. Inc. | 0.51M | -0.31M | -0.10M | 0.25M | -0.30M | -0.63M | 0.45M | 0.14M | 7.40M | 0.03M |
| Net income details | ||||||||||
| EBT | -0.15M | -1.06M | -0.81M | -0.27M | -0.58M | -1.20M | -1.50M | -0.39M | 7.00M | -0.49M |
| Profit After TaxPAT | -0.15M | -1.06M | -0.81M | -0.27M | -0.58M | -1.20M | -1.50M | -0.39M | 7.00M | -0.49M |
| Income from Continuing OperationsIncome (Continuing) | -0.15M | -1.06M | -0.81M | -0.27M | -0.58M | -1.20M | -1.50M | -0.39M | 7.00M | -0.49M |
| Income from Discontinued OperationsIncome (Discontinued) | -0.33M | -0.19M | -0.14M | |||||||
| Consolidated Net IncomeConsol Net Inc. | -0.15M | -1.06M | -0.81M | -0.27M | -0.91M | -1.38M | -1.50M | -0.39M | 6.86M | -0.49M |
| Income towards Parent CompanyParent Net Inc | -0.15M | -1.06M | -0.81M | -0.27M | -0.91M | -1.38M | -0.70M | -0.39M | 6.86M | -0.49M |
| Net Income towards Common StockholdersNet Income | -0.15M | -1.06M | -0.81M | -0.27M | -0.91M | -1.38M | -0.70M | -0.39M | 6.86M | -0.49M |
| Additional items | ||||||||||
| EPS (Basic) | -0.15 | -1.06 | -0.81 | -0.27 | -0.91 | -1.35 | -0.68 | -0.36 | 6.34 | -0.38 |
| EPS (Diluted) | -0.15 | -1.06 | -0.81 | -0.27 | -0.91 | -1.35 | -0.68 | -0.36 | 6.34 | -0.38 |
| Shares Outstanding | 1.00M | 1.00M | 1.00M | 1.00M | 1.00M | 1.02M | 1.03M | 1.08M | 1.08M | 1.28M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 1.00M | 1.00M | 1.00M | 1.00M | 1.00M | 1.02M | 1.03M | 1.08M | 1.08M | 1.28M |
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 1.00M | 1.00M | 1.00M | 1.00M | 1.00M | 1.08M | 1.08M | 1.08M | 1.08M | 1.38M |
| EBITDA | -0.09M | -0.97M | -0.66M | -0.16M | -0.64M | -1.17M | -1.22M | -0.34M | 6.99M | -0.48M |
Pull Advanced Biomed's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=ADVB&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "ADVB", "statement": "IS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=ADVB&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();